Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours.

Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours. Abstract Text:

E Wilander,L Grimelius,G Portela-Gomes,G Lundqvist,V Skoog,P Westermark,

The presence of serotonin, substance P and enteroglucagon was investigated in 8 argentaffin and argyrophil midgut carcinoid tumours. All tumours were argentaffin and displayed formalin-induced fluorescence indicating a content of serotonin. In addition, all 8 tumours showed substance P immunoreactivity and 7 of them enteroglucagon immunoreactivity. The results indicate that the midgut carcinoid tumours are as a rule multihormonal.

Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours. Publishing Authors By Initials

E Wilander,L Grimelius,G Portela-Gomes,G Lundqvist,V Skoog,P Westermark,

For similar peptides: intercellular signaling peptides and proteins: kinins: tachykinins: substance p research abstracts see: peptides: intercellular signaling peptides and proteins: kinins: tachykinins: substance p research

PUBMED ID PMID:

MEDLINE DATE:

Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Scandinavian journal of gastroenterology. Suppleme

VOLUME: 53

Page Numbers: 19-25

Journal Abbreviation: Scand. J. Gastroenterol. Suppl

ISSN: 0085-5928

DAY: 13

MONTH: 02

YEAR: 1979

Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 437034

Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours. Keywords Mesh Terms:

KEYWORDS: Substance P

MESH TERMS: secretion

Chemical & Substance for Abstract: Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours. Information

Substance Name: Glucagon-Like Peptides

Registry Number: 62340-29-8

Grant and Affiliation Information for Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours.

AFFILIATION:

Country: NORWAY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Scand J Gastroenterol Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours Related Publications

• Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I.
• Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
• Amyloid of human islets of Langerhans. II. Electron microscopic analysis of isolated amyloid.
• Amyloidogenic potential of foie gras.
• Amyloidosis in ageing obese-hyperglycemic mice and their lean litter-mates. A morphological study.
• An established human cell line derived from a malignant mediastinal teratoma.
• Density dependent cell cycle inhibition--a universal growth control among normal animal cells.
• Expression of the c-myc proto-oncogene in growth stimulated porcine thyroid follicle cells.
• Germ Line Origin and Somatic Mutations Determine the Target Tissues in Systemic AL-Amyloidosis.
• Growth factor receptors in thyroid follicle cells.
• Growth stimulation of aged cells in culture.
• In vitro differentiation and specialization of cell surfaces in human glia-like cells.
• Lactadherin binds to elastin--a starting point for medin amyloid formation?
• Occurrence of amyloid deposits in the skin in secondary systemic amyloidosis.
• PDGF-like growth factors in autocrine stimulation of growth.
• Plasma membrane motility of cultured human glia cells in phase II and III.
• Psychopathology and personality traits in patients with treated Wilson disease grouped according to gene mutations.
• Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
• Real-time monitoring of apoptosis by caspase-3-like protease induced FRET reduction triggered by amyloid aggregation.
• Role of aggregated medin in the pathogenesis of thoracic aortic aneurysm and dissection.
• Skin involvement in secondary amyloidosis.
• Structural and functional properties of thyroid follicle cells in culture.
• Studies on human foetal endocrine pancreas in vitro.
• Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours.
• The fine structure of growing human glia and glioma cells. Whole cell preparations.
• The pancreatic islets in systemic amyloidosis. The occurrence of two different types of amyloid.
• The spreading of human normal glial and malignant glioma cells in culture. Studies on standard culture conditions.
• Transthyretin and amyloid in the islets of langerhans in type-2 diabetes.
• Ultrastructural features of cultured human glia and glioma cells.
• Unreliability of immunohistochemistry for typing amyloid deposits.